Law Firm Brower Piven Announces Investigation of Cornerstone Therapeutics, Inc. Proposed Acquisition

  Law Firm Brower Piven Announces Investigation of Cornerstone Therapeutics,
  Inc. Proposed Acquisition

Business Wire

STEVENSON, Md. -- September 16, 2013

The securities litigation firm of Brower Piven, A Professional Corporation,
has commenced an investigation into possible breaches of fiduciary duty to
current shareholders of Cornerstone Therapeutics, Inc. (“Cornerstone” or the
“Company”) (NASDAQ: CRTX) and other violations of state law by the board of
directors of Cornerstone relating to the proposed acquisition of the Company
by Chiesi Farmaceutici S.p.A.The firm’s investigation seeks to determine,
among other things, whether the board of directors of Cornerstone breached
their fiduciary duties by failing to maximize shareholder value.

According to the press release announcing the proposed acquisition,
Cornerstone shareholders will receive $9.50 per share in cash for each share
of Cornerstone common stock they own. According to Yahoo! Finance, Cornerstone
common stock has traded above the deal price everyday this month.

If you currently own common stock of Cornerstone and would like to learn more
about the investigation being conducted by Brower Piven, you may email or call
Brower Piven, who will, without obligation or cost to you, attempt to answer
your questions. You may contact Brower Piven by email at
hoffman@browerpiven.com, by calling (410) 415-6616, or at Brower Piven, A
Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153.
Attorneys at Brower Piven have combined experience litigating securities and
other class action cases of over 60 years.

Contact:

Brower Piven, A Professional Corporation
Stevenson, Maryland
Charles J. Piven, 410-415-6616
hoffman@browerpiven.com
 
Press spacebar to pause and continue. Press esc to stop.